Skip to main content

Year: 2024

VALNEVA – Declaration of shares and voting rights: November 30, 2024

VALNEVA Declaration of shares and voting rights November 30, 2024__________________________________________________________________________________________ Company name: VALNEVARegistered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France)Regulated market of Euronext Paris – Compartment B Declaration date: December 5, 2024Number of shares composing the share capital of Valneva Total number of voting rights including suspended voting rights* Description of the change Date on which this change was recognized Total number of voting rights excluding suspended voting rights** 162,494,003  ordinary shares with a par value of €0.15 each 178,371,727Transfer into bearer form of 1,000 shares with double voting rights   Double voting rights granted on 7,052 ordinary shares   November...

Continue reading

Press release – SPIE signs an agreement for the acquisition of Corporate Software in Switzerland

Cergy, December 5th, 2024 – SPIE, the independent European leader in multi-technical services in the areas of energy and communications, announces the signing of an agreement to acquire 100% of Corporate Software AG in Switzerland. Corporate Software AG was founded in 2011 and has developed itself as a trusted IT consulting and service provider in Switzerland. The company provides IT and business application solutions with a strong focus and experience in digitalization and cloud services. Corporate Software AG generated c.€4 million revenue in FY 2024 (financial year being closed in June 2024) and employs 21 highly skilled people.This acquisition will enable SPIE to further expand its footprint in Switzerland and further deploy its expertise in automation, data analytics and AI1-driven solutions. It will strengthen our ability to deliver...

Continue reading

Greif, Inc. Issues Corrected Fourth Quarter and Fiscal Year 2024 Earnings Release

Corrected fourth quarter 2024 net income, excluding adjustments, revised to $65.5 million and 2024 Class A diluted earnings per share, excluding adjustments, revised to $1.13 DELAWARE, Ohio, Dec. 04, 2024 (GLOBE NEWSWIRE) — Greif, Inc. (NYSE: GEF, GEF.B), has issued a revised earnings release to correct an error in the previously issued press release titled “Greif Reports Fourth Quarter and Fiscal 2024 Results” (the “Prior Earnings Release”) issued on December 4, 2024 at 04:01 PM ET. In the Prior Earnings Release, the fourth quarter 2024 net income, excluding the impact of adjustments, incorrectly presented a $16.0 million income tax expense related to “(gain) loss on disposal of businesses, net.” This resulted in stating net income, excluding the impact of adjustments, for the period of $49.6 million and diluted Class A earnings...

Continue reading

Nokia’s Bell Labs Consulting and stc Group unveil generative AI solution to streamline integration and enhance user experience

Press ReleaseNokia’s Bell Labs Consulting and stc Group unveil generative AI solution to streamline integration and enhance user experienceThe Bell Labs Consulting streamlined solution reduces the time new developments take to reach the market, decreases development costs and increases overall efficiency. stc Group expects this move will transform the network ecosystem, optimizing existing and new services. The addition of generative AI capabilities will support stc’s commitment to driving digital transformation across its operations.5 December 2024Espoo, Finland – Bell Labs Consulting and Saudi Arabia’s leading digital enabler, stc Group, announced today the successful trial of a pioneering generative AI solution that will streamline service provision, reduce time to market, lower costs and significantly increase overall efficiency. The...

Continue reading

CORRECTION – Greif Reports Fourth Quarter and Fiscal 2024 Results

DELAWARE, Ohio, Dec. 04, 2024 (GLOBE NEWSWIRE) — Correction: Fourth quarter 2024 net income, excluding the impact of adjustments, revised to $65.5 million and 2024 Class A diluted earnings per share, excluding adjustments, revised to $1.13. In the earnings release issued earlier today, the fourth quarter 2024 net income, excluding the impact of adjustments, incorrectly presented a $16.0 million income tax expense related to “(gain) loss on disposal of businesses, net”. This resulted in stating net income, excluding the impact of adjustments, for the period of $49.6 million and diluted Class A earnings per share, excluding adjustments, for the period of $0.85. The corrected net income, excluding the impact of adjustments, for the period is $65.5 million, and the corrected diluted Class A earnings per share, excluding adjustments,...

Continue reading

High Arctic Overseas Announces Issuance of Stock Options

CALGARY, Alberta, Dec. 04, 2024 (GLOBE NEWSWIRE) — High Arctic Overseas Holdings Corp. (TSXV: HOH) (“High Arctic Overseas” or the “Corporation”) announces that it has issued an aggregate of 675,000 incentive stock options to its directors and senior officers. Each option entitles the holder to purchase one common share of the Corporation at an exercise price of $1.60 for a period of five (5) years. The options will vest over a period of three (3) years, with one third of the options vesting each year, however, the options issued to one senior officer will vest after one year as to 100% of the options, representing a total of 25,000 options. The stock options were granted pursuant to the Corporation’s Omnibus Incentive Plan, a copy of which is available on the Corporation’s SEDAR+ profile at https://www.sedarplus.ca. About High...

Continue reading

Cambium Bio Successfully Closes A$3.0M Financing Round

SYDNEY, Dec. 05, 2024 (GLOBE NEWSWIRE) —  Cambium Bio Limited (ASX:CMB) (Cambium Bio, Cambium or Company), a clinical-stage regenerative medicine company focusing on the development of innovative biologics for ophthalmology and tissue repair applications, is pleased to announce the successful completion of a A$3.0 million capital raising. Key Highlights:Capital raising of A$3.0 million completed at A$0.4637 per share, representing a 25% discount to the 5-day Volume Weighted Average Price (VWAP) up to and including 2 December 2024 Strong support from new strategic investor AventaCell Biomedical Corp and existing major shareholder Zheng Yang Biomedical Technology Additional participation from Cambium Bio directors, CEO, and Australian institutional and sophisticated investors Proceeds to advance Phase 3 clinical development of...

Continue reading

zSpace Announces Pricing of $9.4 Million Initial Public Offering

SAN JOSE, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) — zSpace, Inc. (“ZSPC” or the “Company”) today announced the pricing of its firm commitment initial public offering of an aggregate of 1,875,000 shares of its Common Stock (the “Offering”) at $5.00 per share. The gross proceeds to ZSPC from the Offering, before deducting underwriting discounts and commissions and estimated offering expenses payable by ZSPC, is expected to be approximately $9.4 million without the exercise of the underwriters’ over-allotment option. The shares are expected to begin trading on the Nasdaq Global Market under the ticker symbol “ZSPC” at the open of the market on December 5, 2024. The Offering is expected to close on December 6, 2024, subject to customary closing conditions. In connection with the Offering, the Company has granted the underwriters a 30-day...

Continue reading

Correction to Press Release Announcing nCino’s Third Quarter Fiscal Year 2025 Financial Results

Correcting Guidance for Fiscal Year 2025 Non-GAAP net income attributable to nCino per diluted share Total Revenues of $138.8M, up 14% year-over-year Subscription Revenues of $119.9M, up 14% year-over-year GAAP Operating Margin of (1)%, up ~1,000 basis points year-over-year Non-GAAP Operating Margin of 20%, up ~350 basis points year-over-yearWILMINGTON, N.C., Dec. 04, 2024 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, today announced financial results for the third quarter of fiscal year 2025, ended October 31, 2024. “We are very pleased with our third quarter results, once again exceeding expectations for both revenues and non-GAAP operating income,” said Pierre Naudé, Chairman and CEO at nCino. “The team delivered solid execution globally,...

Continue reading

KMT-Hansa Announces Debt Conversion

TORONTO, Dec. 04, 2024 (GLOBE NEWSWIRE) — KMT-Hansa Corp. (the “Corporation”) would like to announce that it has agreed to settle (collectively, the “Debt Settlements”) an aggregate of $940,024.92 debt to four (4) arm’s length creditors. The Debt Settlements will be comprised of:(i) an aggregate of $400,000 debt through the issuance of a convertible debenture (the “Debentures”); and(ii) an aggregate of $540,024.92 debt owed to four (4) arm’s length creditors through the issuance of 13,500,623common shares (the “Debt Shares”) at a deemed price of $0.04 per Debt Share. The Debentures shall bear interest at 7% per annum from the date of issuance and shall mature on the date that is one (1) year from the date of issuance (the “Maturity Date”). The Debentures will be convertible, in whole or in part, into one (1) unit (each,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.